Team Management of Skin Rash Associated with Use of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
Objective: The aim of this study was to evaluate the effectiveness of a rash team management intervention designed by certified nurses, medical physicians, and certified pharmacists. The quality of life (QOL) of patients administered epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors...
Main Authors: | Katsuhiro Masago, Fumiko Imamichi, Yoshio Masuda, Noriko Ariga, Kiyomi Fujitomi, Yoko Fukumine, Kana Hatakenaka, Shiro Fujita, Nobuyuki Katakami |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-01-01
|
Series: | Asia-Pacific Journal of Oncology Nursing |
Subjects: | |
Online Access: | http://www.apjon.org/article.asp?issn=2347-5625;year=2018;volume=5;issue=4;spage=430;epage=434;aulast=Masago |
Similar Items
-
Toxic epidermal necrolysis-like rash of lupus: A dermatologist′s dilemma
by: Brahmita Monga, et al.
Published: (2014-01-01) -
Konjenital yaygın epidermal nevüs
by: Tugay TEPE, et al.
Published: (2018-12-01) -
Good Clinical Response to Erlotinib in a Non-Small Cell Lung Cancer Patient Harboring Multiple Brain Metastases and a Double Active Somatic Epidermal Growth Factor Gene Mutation
by: Katsuhiro Masago, et al.
Published: (2010-04-01) -
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Should Be Kept in Mind in Children with Febrile Neutropenia, Oral Cavity Lesions, and Skin Rash
by: Eda Ataseven, et al.
Published: (2016-05-01) -
Customized chemotherapy based on <it>epidermal growth factor receptor</it> mutation status for elderly patients with advanced non-small-cell lung cancer: a phase II trial
by: Fujita Shiro, et al.
Published: (2012-05-01)